U.S. Markets close in 4 hrs 14 mins

Natural Health Trends Corp. (NHTC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.52-0.05 (-0.90%)
As of 11:35AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.57
Open5.62
Bid5.52 x 900
Ask5.53 x 1100
Day's Range5.52 - 5.62
52 Week Range2.52 - 8.27
Volume4,785
Avg. Volume22,067
Market Cap63.052M
Beta (5Y Monthly)0.71
PE Ratio (TTM)N/A
EPS (TTM)-0.26
Earnings DateNov 04, 2020
Forward Dividend & Yield0.80 (14.65%)
Ex-Dividend DateNov 16, 2020
1y Target EstN/A
  • GlobeNewswire

    Update in Lawsuit for Investors in shares of Becton, Dickinson and Company (NYSE: BDX) announced by Shareholders Foundation

    SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: BDX shares. Investors, who purchased NYSE: BDX shares in November 2019 or earlier and continue to hold any of those NYSE: BDX shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On February 27, 2020, a lawsuit was filed against Becton, Dickinson and Company over alleged violations of securities laws. The plaintiff alleged that the defendants failed to disclose to investors that certain of Becton’s Alaris infusion pumps experienced software errors and alarm prioritization issues, that, as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to “make enhancements”, that the Company was reasonably likely to face regulatory delays in connection with the software remediation, that, as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis. On August 10, 2020, an amended complaint was filed and on October 9, 2020, the defendants filed their motion to dismiss the case. Those who purchased Becton, Dickinson and Company (NYSE: BDX) shares should contact the Shareholders Foundation, Inc. CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108 The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

  • BD Names CEO Tom Polen as Chairman of the Board
    PR Newswire

    BD Names CEO Tom Polen as Chairman of the Board

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president, will assume additional responsibility as chairman of the BD board of directors, effective April 28, 2021. Polen will succeed Vincent A. Forlenza, who will retire from BD at that time.

  • BD Board Declares Dividend
    PR Newswire

    BD Board Declares Dividend

    The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on March 31, 2021 to holders of record on March 10, 2021. The indicated annual dividend rate is $3.32 per share.